Q4 2015 Holdings
Filed 2016-02-12 | 53 holdings | $19.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $10.6M | 2,120,000 | 55.4% |
| Codexis Inc(CDXS) | COM | 192005106 | $6.8M | 1,600,000 | 35.4% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $1.6M | 50,000 | 8.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $12.3K | 110,000 | 0.1% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $9.9K | 325,000 | 0.1% |
| Geron Corp(GERN) | COM | 374163103 | $8.8K | 1,825,000 | 0.0% |
| Medgenics Inc | COM NEW | 58436Q203 | $8.4K | 1,390,000 | 0.0% |
| Imprimis Pharmaceuticals Inc | COM NEW | 45323A201 | $8.4K | 1,205,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365AAB7 | $8.3K | 8,100,000 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $8.2K | 105,000 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $8.2K | 1,310,000 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $7.5K | 85,000 | 0.0% |
| Inotek Pharmaceuticals Corp | COM | 45780VAA0 | $7.3K | 645,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $7.2K | 275,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $7.2K | 427,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $6.7K | 345,000 | 0.0% |
| Relypsa Inc | COM | 759531106 | $6.2K | 220,000 | 0.0% |
| Cempra Inc | COM | 15130J109 | $6.2K | 200,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $5.8K | 100,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $5.6K | 420,000 | 0.0% |
| Depomed Inc | COM | 249908104 | $5.4K | 300,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $5.4K | 190,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $4.5K | 150,000 | 0.0% |
| Tonix Pharmaceuticals Hldg C | COM NEW | 890260201 | $4.3K | 565,000 | 0.0% |
| Avinger Inc | COM | 053734109 | $4.3K | 190,000 | 0.0% |
| Affimed N V | COM | N01045108 | $4.2K | 595,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $4.1K | 500,000 | 0.0% |
| Cytrx Corp | COM PAR $.001 | 838828509 | $3.8K | 1,440,000 | 0.0% |
| LA Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459904 | $3.8K | 140,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.6K | 300,000 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $3.4K | 630,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $3.3K | 1,760,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.1K | 55,000 | 0.0% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $3.1K | 250,000 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $2.9K | 300,000 | 0.0% |
| Corium Intl Inc | COM | 21887L107 | $2.9K | 355,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $2.6K | 210,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.4K | 300,000 | 0.0% |
| Xoma Corp del | COM | 98419J107 | $2.3K | 1,700,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L105 | $2.2K | 150,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $2.1K | 65,000 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $2.1K | 220,000 | 0.0% |
| Auris MED Hldg AG | COM | H03579101 | $1.8K | 375,000 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $1.8K | 540,000 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $1.7K | 110,000 | 0.0% |
| Accelerated Diagnostics Inc | COM | 00430H102 | $1.6K | 75,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.1K | 35,000 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $1.1K | 58,500 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $890 | 290,000 | 0.0% |
| Achaogen Inc | COM | OO4449104 | $718 | 125,000 | 0.0% |